Market Cap 12.13B
Revenue (ttm) 958.40M
Net Income (ttm) -288.28M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -30.08%
Debt to Equity Ratio 0.65
Volume 356,100
Avg Vol 387,310
Day's Range N/A - N/A
Shares Out 23.10M
Stochastic %K 59%
Beta -1.01
Analysts Strong Sell
Price Target $670.89

Company Profile

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company was founded in 2016 and is headquartered in West Conshohocken, Pennsylvania.

Industry: Biotechnology
Sector: Healthcare
Phone: 267 824 2827
Address:
Four Tower Bridge, 200 Barr Harbor Drive Suite 200, West Conshohocken, United States
MurrayKummer360
MurrayKummer360 Aug. 19 at 9:09 AM
$KO $BRUN $SPOT $MDGL Coca-Cola benefits from resilient beverage demand and pricing, BRUN remains speculative, Spotify benefits from subscriber and advertising growth, and Madrigal advances metabolic-disease treatments. I'm watching volume growth, liquidity, subscriptions, advertising, and clinical or commercial milestones.
0 · Reply
CDSTrading
CDSTrading Aug. 19 at 8:58 AM
$KO $BRUN $SPOT $MDGL Coca-Cola benefits from resilient beverage demand and pricing, BRUN remains speculative, Spotify benefits from subscriber and advertising growth, and Madrigal advances metabolic-disease treatments. I'm watching volume growth, liquidity, subscriptions, advertising, and clinical or commercial milestones.
0 · Reply
Wallst45
Wallst45 Aug. 18 at 7:30 PM
$MDGL shorts covering like yesterday again
2 · Reply
ReapN
ReapN Aug. 18 at 3:56 PM
$SLS has TWO niche Products GPS - 009 - The only ones who ’know’ (real Doctors) are in a quiet phase. IF a poster tries to sound ’scientific’ you can immediately deduce the post is FUD Block the noise, get to work, pay it forward $CPXX $MDGL follow the money
1 · Reply
wizeinvesting
wizeinvesting Aug. 18 at 8:30 AM
$MDGL $ORCL $INOD $STRL $APP A falling stock price can make even a strong business look broken, especially when negative headlines start dominating the conversation. But beneath the market noise, some companies continue growing revenue, building backlogs, expanding into powerful long-term markets, or strengthening their competitive positions. From AI infrastructure and cloud spending to power demand, digital advertising, and speculative growth opportunities, the real question is not simply why these... https://www.wizeinvesting.com/p/mdgl-s-530-rise-how-steady-investing-could-multiply
1 · Reply
Wallst45
Wallst45 Aug. 17 at 8:04 PM
$MDGL why we running hard into close ??
0 · Reply
JimmyOcarri
JimmyOcarri Aug. 17 at 7:58 PM
0 · Reply
AnalyticalOne
AnalyticalOne Aug. 17 at 1:38 PM
$EYPT $MDB $YSS $MDGL SuperPuncher likes to say I told you so when he doesn't say he told you so. SuperPuncher likes to say he doesn't do that but please click on his profile and see his ridiculous posts🤣🤣🤣 What a troll! All he does is go to different stocks and say I said this was going to happen. Not!!
1 · Reply
Live2ride
Live2ride Aug. 14 at 1:38 PM
$MDGL Sorry guys. Wrong ticker. Thought I was on AXSM board.
0 · Reply
Live2ride
Live2ride Aug. 14 at 1:29 PM
$MDGL scripts stuck at 19,700 now for 4 straight weeks.
2 · Reply
Latest News on MDGL
Madrigal Appoints John C. Reed, M.D.

Aug 12, 2026, 8:00 AM EDT - 7 days ago

Madrigal Appoints John C. Reed, M.D.

MDGL


Madrigal Pharmaceuticals Earnings Call Transcript: Q2 2026

Jul 30, 2026, 8:00 AM EDT - 20 days ago

Madrigal Pharmaceuticals Earnings Call Transcript: Q2 2026


Madrigal Pharmaceuticals Earnings release: Q2 2026

Jul 30, 2026, 8:00 AM EDT - 20 days ago

Madrigal Pharmaceuticals Earnings release: Q2 2026


Madrigal Pharmaceuticals Slides: Q2 2026

Jul 30, 2026, 8:00 AM EDT - 20 days ago

Madrigal Pharmaceuticals Slides: Q2 2026


Madrigal Pharmaceuticals Quarterly report: Q2 2026

Jul 30, 2026, 8:00 AM EDT - 20 days ago

Madrigal Pharmaceuticals Quarterly report: Q2 2026


Madrigal Pharmaceuticals Earnings Call Transcript: Q1 2026

May 6, 2026, 8:00 AM EDT - 3 months ago

Madrigal Pharmaceuticals Earnings Call Transcript: Q1 2026


Madrigal Pharmaceuticals Earnings release: Q1 2026

May 6, 2026, 8:00 AM EDT - 3 months ago

Madrigal Pharmaceuticals Earnings release: Q1 2026


Madrigal Pharmaceuticals Slides: Q1 2026

May 6, 2026, 8:00 AM EDT - 3 months ago

Madrigal Pharmaceuticals Slides: Q1 2026


Madrigal Pharmaceuticals Quarterly report: Q1 2026

May 6, 2026, 8:00 AM EDT - 3 months ago

Madrigal Pharmaceuticals Quarterly report: Q1 2026


Madrigal Pharmaceuticals Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 4 months ago

Madrigal Pharmaceuticals Proxy statement: Proxy filing


Madrigal Pharmaceuticals Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 4 months ago

Madrigal Pharmaceuticals Proxy statement: Proxy filing


Madrigal Pharmaceuticals Earnings Call Transcript: Q4 2025

Feb 19, 2026, 8:00 AM EST - 6 months ago

Madrigal Pharmaceuticals Earnings Call Transcript: Q4 2025


Madrigal Pharmaceuticals Annual report: Q4 2025

Feb 19, 2026, 8:00 AM EST - 6 months ago

Madrigal Pharmaceuticals Annual report: Q4 2025


Madrigal Pharmaceuticals Earnings release: Q4 2025

Feb 19, 2026, 8:00 AM EST - 6 months ago

Madrigal Pharmaceuticals Earnings release: Q4 2025


Madrigal Pharmaceuticals Slides: Q4 2025

Feb 19, 2026, 8:00 AM EST - 6 months ago

Madrigal Pharmaceuticals Slides: Q4 2025


Madrigal Pharmaceuticals Earnings Call Transcript: Q3 2025

Nov 4, 2025, 8:00 AM EST - 10 months ago

Madrigal Pharmaceuticals Earnings Call Transcript: Q3 2025


Madrigal Pharmaceuticals Quarterly report: Q3 2025

Nov 4, 2025, 8:00 AM EST - 10 months ago

Madrigal Pharmaceuticals Quarterly report: Q3 2025


Madrigal Pharmaceuticals Earnings release: Q3 2025

Nov 4, 2025, 8:00 AM EST - 10 months ago

Madrigal Pharmaceuticals Earnings release: Q3 2025


Madrigal Pharmaceuticals Slides: Q3 2025

Nov 4, 2025, 8:00 AM EST - 10 months ago

Madrigal Pharmaceuticals Slides: Q3 2025


Madrigal Pharmaceuticals Earnings Call Transcript: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Madrigal Pharmaceuticals Earnings Call Transcript: Q2 2025


Madrigal Pharmaceuticals Quarterly report: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Madrigal Pharmaceuticals Quarterly report: Q2 2025


Madrigal Pharmaceuticals Earnings release: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Madrigal Pharmaceuticals Earnings release: Q2 2025


Madrigal Pharmaceuticals Slides: Q2 2025

Aug 5, 2025, 8:00 AM EDT - 1 year ago

Madrigal Pharmaceuticals Slides: Q2 2025


Madrigal Pharmaceuticals Transcript: Status Update

May 13, 2025, 8:00 AM EDT - 1 year ago

Madrigal Pharmaceuticals Transcript: Status Update


Madrigal Pharmaceuticals Earnings Call Transcript: Q1 2025

May 1, 2025, 8:00 AM EDT - 1 year ago

Madrigal Pharmaceuticals Earnings Call Transcript: Q1 2025


Madrigal Pharmaceuticals Quarterly report: Q1 2025

May 1, 2025, 8:00 AM EDT - 1 year ago

Madrigal Pharmaceuticals Quarterly report: Q1 2025


Madrigal Pharmaceuticals Earnings release: Q1 2025

May 1, 2025, 8:00 AM EDT - 1 year ago

Madrigal Pharmaceuticals Earnings release: Q1 2025


Madrigal Pharmaceuticals Slides: Q1 2025

May 1, 2025, 8:00 AM EDT - 1 year ago

Madrigal Pharmaceuticals Slides: Q1 2025


Madrigal Pharmaceuticals Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Madrigal Pharmaceuticals Proxy statement: Proxy Filing


Madrigal Pharmaceuticals Proxy statement: Proxy Filing

Apr 29, 2025, 8:00 AM EDT - 1 year ago

Madrigal Pharmaceuticals Proxy statement: Proxy Filing


Madrigal Appoints Jacqualyn A. Fouse, Ph.D.

Mar 11, 2025, 8:00 AM EDT - 1 year ago

Madrigal Appoints Jacqualyn A. Fouse, Ph.D.

MDGL


Madrigal Pharmaceuticals Earnings Call Transcript: Q4 2024

Feb 26, 2025, 8:00 AM EST - 1 year ago

Madrigal Pharmaceuticals Earnings Call Transcript: Q4 2024


Madrigal Pharmaceuticals Annual report: Q4 2024

Feb 26, 2025, 8:00 AM EST - 1 year ago

Madrigal Pharmaceuticals Annual report: Q4 2024


Madrigal Pharmaceuticals Earnings release: Q4 2024

Feb 26, 2025, 8:00 AM EST - 1 year ago

Madrigal Pharmaceuticals Earnings release: Q4 2024


Madrigal Pharmaceuticals Slides: Q4 2024

Feb 26, 2025, 8:00 AM EST - 1 year ago

Madrigal Pharmaceuticals Slides: Q4 2024


MurrayKummer360
MurrayKummer360 Aug. 19 at 9:09 AM
$KO $BRUN $SPOT $MDGL Coca-Cola benefits from resilient beverage demand and pricing, BRUN remains speculative, Spotify benefits from subscriber and advertising growth, and Madrigal advances metabolic-disease treatments. I'm watching volume growth, liquidity, subscriptions, advertising, and clinical or commercial milestones.
0 · Reply
CDSTrading
CDSTrading Aug. 19 at 8:58 AM
$KO $BRUN $SPOT $MDGL Coca-Cola benefits from resilient beverage demand and pricing, BRUN remains speculative, Spotify benefits from subscriber and advertising growth, and Madrigal advances metabolic-disease treatments. I'm watching volume growth, liquidity, subscriptions, advertising, and clinical or commercial milestones.
0 · Reply
Wallst45
Wallst45 Aug. 18 at 7:30 PM
$MDGL shorts covering like yesterday again
2 · Reply
ReapN
ReapN Aug. 18 at 3:56 PM
$SLS has TWO niche Products GPS - 009 - The only ones who ’know’ (real Doctors) are in a quiet phase. IF a poster tries to sound ’scientific’ you can immediately deduce the post is FUD Block the noise, get to work, pay it forward $CPXX $MDGL follow the money
1 · Reply
wizeinvesting
wizeinvesting Aug. 18 at 8:30 AM
$MDGL $ORCL $INOD $STRL $APP A falling stock price can make even a strong business look broken, especially when negative headlines start dominating the conversation. But beneath the market noise, some companies continue growing revenue, building backlogs, expanding into powerful long-term markets, or strengthening their competitive positions. From AI infrastructure and cloud spending to power demand, digital advertising, and speculative growth opportunities, the real question is not simply why these... https://www.wizeinvesting.com/p/mdgl-s-530-rise-how-steady-investing-could-multiply
1 · Reply
Wallst45
Wallst45 Aug. 17 at 8:04 PM
$MDGL why we running hard into close ??
0 · Reply
JimmyOcarri
JimmyOcarri Aug. 17 at 7:58 PM
0 · Reply
AnalyticalOne
AnalyticalOne Aug. 17 at 1:38 PM
$EYPT $MDB $YSS $MDGL SuperPuncher likes to say I told you so when he doesn't say he told you so. SuperPuncher likes to say he doesn't do that but please click on his profile and see his ridiculous posts🤣🤣🤣 What a troll! All he does is go to different stocks and say I said this was going to happen. Not!!
1 · Reply
Live2ride
Live2ride Aug. 14 at 1:38 PM
$MDGL Sorry guys. Wrong ticker. Thought I was on AXSM board.
0 · Reply
Live2ride
Live2ride Aug. 14 at 1:29 PM
$MDGL scripts stuck at 19,700 now for 4 straight weeks.
2 · Reply
Biotech_Beast
Biotech_Beast Aug. 14 at 1:19 PM
$ALT is underway with its phase 3 MASH trial, although a result might not come until 2029. There is a phase 2 in alcohol-associated liver disease on tap for 2027, with a recent study in alcohol use disorder producing positive results. $MDGL https://seekingalpha.com/article/4936237-altimmune-pemvidutide-performs-but-a-long-wait-ahead
0 · Reply
SuperPuncher
SuperPuncher Aug. 13 at 11:36 PM
$MDGL I knew it
1 · Reply
Live2ride
Live2ride Aug. 13 at 8:00 PM
$MDGL I may regret those swing shares. This drop feels fishy. Absolutely no buying today.
1 · Reply
Wallst45
Wallst45 Aug. 13 at 6:56 PM
$MDGL great news
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Aug. 13 at 6:40 PM
$MDGL somebody has been unloading shares all day...
1 · Reply
sarkar20
sarkar20 Aug. 13 at 5:16 PM
$MDGL https://www.tipranks.com/news/company-announcements/madrigal-extends-resmetirom-into-pediatric-mash-boosting-long-term-upside-for-mdgl
0 · Reply
Live2ride
Live2ride Aug. 13 at 5:15 PM
$MDGL Come on down. Need some swing shares.
1 · Reply
Wallst45
Wallst45 Aug. 13 at 4:06 AM
$MDGL The company said $NVO Wegovy is functioning more as background therapy than as a direct competitor. Source: https://x.com/wallstsai/status/2087565996013854893?s=46
0 · Reply
Whiskeyunderthebed
Whiskeyunderthebed Aug. 12 at 5:00 PM
$MDGL https://www.biospace.com/press-releases/madrigal-appoints-john-c-reed-m-d-ph-d-to-its-board-of-directors
0 · Reply
Wallst45
Wallst45 Aug. 12 at 3:44 PM
$MDGL now back to 570
1 · Reply
Live2ride
Live2ride Aug. 12 at 3:36 PM
$MDGL Well, filled that gap faster than I thought. Lightening up on swing shares. GLTA
0 · Reply
Wallst45
Wallst45 Aug. 12 at 3:36 PM
$MDGL squeeze higher
0 · Reply